176 related articles for article (PubMed ID: 27235448)
1. Haplotype and diplotype analyses of variation in ERCC5 transcription cis-regulation in normal bronchial epithelial cells.
Zhang X; Crawford EL; Blomquist TM; Khuder SA; Yeo J; Levin AM; Willey JC
Physiol Genomics; 2016 Jul; 48(7):537-43. PubMed ID: 27235448
[TBL] [Abstract][Full Text] [Related]
2. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
Blomquist TM; Crawford EL; Willey JC
Carcinogenesis; 2010 Jul; 31(7):1242-50. PubMed ID: 20233728
[TBL] [Abstract][Full Text] [Related]
3. RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs.
Yeo J; Morales DA; Chen T; Crawford EL; Zhang X; Blomquist TM; Levin AM; Massion PP; Arenberg DA; Midthun DE; Mazzone PJ; Nathan SD; Wainz RJ; Nana-Sinkam P; Willey PFS; Arend TJ; Padda K; Qiu S; Federov A; Hernandez DR; Hammersley JR; Yoon Y; Safi F; Khuder SA; Willey JC
BMC Pulm Med; 2018 Mar; 18(1):42. PubMed ID: 29506519
[TBL] [Abstract][Full Text] [Related]
4. Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese.
Duan Z; He C; Gong Y; Li P; Xu Q; Sun LP; Wang Z; Xing C; Yuan Y
Gene; 2012 Dec; 511(2):274-9. PubMed ID: 22982416
[TBL] [Abstract][Full Text] [Related]
5. Impact of SNP-SNP interactions of DNA repair gene
Sang L; Lv Z; Sun LP; Xu Q; Yuan Y
World J Gastroenterol; 2018 Feb; 24(5):602-612. PubMed ID: 29434449
[TBL] [Abstract][Full Text] [Related]
6. Association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population.
Li RJ; Li M; Liu GJ; Guo YW; Bai H; Xiao P; Mei JZ
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051028
[TBL] [Abstract][Full Text] [Related]
7. Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy.
Chen J; Luo X; Xie G; Chen K; Jiang H; Pan F; Li J; Ruan Z; Pang X; Liang H
Medicine (Baltimore); 2016 May; 95(19):e3652. PubMed ID: 27175691
[TBL] [Abstract][Full Text] [Related]
8. Association between ERCC5 gene polymorphisms and breast cancer risk.
Na N; Dun E; Ren L; Li G
Int J Clin Exp Pathol; 2015; 8(3):3192-7. PubMed ID: 26045839
[TBL] [Abstract][Full Text] [Related]
9. Association of ERCC5 Genetic Polymorphisms With Cirrhosis and Liver Cancer.
Yang G; Yang Y; Ma X; Huang L; Li W; Song X; Zhang H; Liu W; Lu J
Technol Cancer Res Treat; 2020; 19():1533033820943244. PubMed ID: 32812509
[TBL] [Abstract][Full Text] [Related]
10. Study on association between ERCC5 single nucleotide polymorphism and susceptibility to esophageal cancer.
Zhang C; Liao Z; Yu G; Huang W; Song X
J BUON; 2017; 22(4):979-984. PubMed ID: 28952217
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the ERCC5 gene and risk of esophageal squamous cell carcinoma (ESCC) in Eastern Chinese populations.
Zhu ML; Shi TY; Hu HC; He J; Wang M; Jin L; Yang YJ; Wang JC; Sun MH; Chen H; Zhao KL; Zhang Z; Chen HQ; Xiang JQ; Wei QY
PLoS One; 2012; 7(7):e41500. PubMed ID: 22848513
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China.
Hussain SK; Mu LN; Cai L; Chang SC; Park SL; Oh SS; Wang Y; Goldstein BY; Ding BG; Jiang Q; Rao J; You NC; Yu SZ; Papp JC; Zhao JK; Wang H; Zhang ZF
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2304-9. PubMed ID: 19661089
[TBL] [Abstract][Full Text] [Related]
13. Association analysis of ERCC5 gene polymorphisms with risk of breast cancer in Han women of northwest China.
Wang H; Wang T; Guo H; Zhu G; Yang S; Hu Q; Du Y; Bai X; Chen X; Su H
Breast Cancer; 2016 May; 23(3):479-85. PubMed ID: 25644244
[TBL] [Abstract][Full Text] [Related]
14. Laryngeal cancer risk and common single nucleotide polymorphisms in nucleotide excision repair pathway genes ERCC1, ERCC2, ERCC3, ERCC4, ERCC5 and XPA.
Lu B; Li J; Gao Q; Yu W; Yang Q; Li X
Gene; 2014 May; 542(1):64-8. PubMed ID: 24582975
[TBL] [Abstract][Full Text] [Related]
15.
Liu ZQ; Chen GG; Sun RL; Chen C; Lu MY; Guan LF; Chi XL; Jian YQ; Zhu X; Liu RQ; Cai BY; Chen FF; Liu B
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30139812
[No Abstract] [Full Text] [Related]
16. XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer.
Wang F; Zhang SD; Xu HM; Zhu JH; Hua RX; Xue WQ; Li XZ; Wang TM; He J; Jia WH
Oncotarget; 2016 Mar; 7(10):11724-32. PubMed ID: 26887052
[TBL] [Abstract][Full Text] [Related]
17. Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer.
He C; Duan Z; Li P; Xu Q; Yuan Y
Anticancer Drugs; 2013 Mar; 24(3):300-5. PubMed ID: 23211354
[TBL] [Abstract][Full Text] [Related]
18. Variants of ERCC5 and the outcome of platinum-based regimens in non-small cell lung cancer: a prospective cohort study.
Abdalkhalek ES; Wakeel LME; Nagy AA; Sabri NA
Med Oncol; 2022 Jul; 39(10):152. PubMed ID: 35852645
[TBL] [Abstract][Full Text] [Related]
19. XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies.
Huang J; Liu X; Tang LL; Long JT; Zhu J; Hua RX; Li J
Oncotarget; 2017 Jun; 8(23):37263-37277. PubMed ID: 28416771
[TBL] [Abstract][Full Text] [Related]
20. Investigation on ERCC5 genetic polymorphisms and the development of gastric cancer in a Chinese population.
Yang LQ; Zhang Y; Sun HF
Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
